☆ 4.8 Article

Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session

JOURNAL OF CONTROLLED RELEASE (2020)

Get Full Text
Add to Collection

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 323, Issue -, Pages 269-281

Publisher

ELSEVIER
DOI: 10.1016/j.jconrel.2020.04.030

Keywords

-

Categories

Chemistry, Multidisciplinary Pharmacology & Pharmacy

Funding

  1. European Research Council under the European Union's Horizon 2020 research and innovation programme [677582]
  2. European Research Council (ERC) [677582] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.